Digitisation | June 20, 2025
Healthcare Triangle launches Malaysian subsidiary QuantumNexis
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
Speakers for the session are: Dr. Richard Lobo, Global Head Business Excellence, Innovation, R&D and Chief Ethics Counsellor, Tata Chemicals; Dr. Debabrata Rautaray, Vice President and Chief Product Development & Innovation Officer, DCM Shriram Chemicals Innovation Centre; Dr. Prashant Puri, Head - R&D, Deepak Fertilizers and Petrochemicals Corporation (DFPCL); Dr. Deepak S Panmand, General Manager (R&D), Dhanuka Agritech; Dr. Mudassir. K. Munshi, Team Leader, Deepak Nitrite; and Dr. Manish M. Khandagale, Senior Field Application Specialist, Revvity Signals
ekincare has raised a total funding of $22M since 2015 till date
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
David joins HCTI with a distinguished career of over 22 years of corporate finance experience
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
The PIPE offering consists of 36,190,476 units
Subscribe To Our Newsletter & Stay Updated
